Published in TB and Outbreaks Week, July 4th, 2006
According to a recent report from Cuba, "Standardized allergen vaccines have been developed and registered as biopharmaceutical products in Cuba. Three different vaccines were obtained from the most relevant allergenic mite species: Dermatophagoides pteronyssinus, Dermatophagoides siboney, and Blomia tropicalis.
"Preclinical and clinical studies showed efficacy...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.